ST PHARM CO., LTD. Logo

ST PHARM CO., LTD.

A global CDMO specializing in APIs and RNA therapeutics for the gene therapy market.

237690 | KO

Overview

Corporate Details

ISIN(s):
KR7237690003
LEI:
Country:
South Korea
Address:
경기도 시흥시 협력로 231(정왕동, 시화공단 1나 802호), 시흥시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ST Pharm Co., Ltd. is a global Contract Development and Manufacturing Organization (CDMO) specializing in Active Pharmaceutical Ingredients (APIs) for the gene therapy market. The company is a key manufacturer of RNA-based therapeutics, with technology-driven services spanning from oligonucleotides to xRNA and mRNA. ST Pharm provides comprehensive, cGMP-compliant custom manufacturing solutions for both novel and generic drugs. With over 30 years of experience, the company supports its global partners through the entire development lifecycle, from research and development to commercial-scale production, quality control, and regulatory affairs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 8.3 KB
2025-09-08 00:00
Share Issue/Capital Change
전환청구권행사
Korean 10.8 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 3.4 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.6 MB
2025-08-13 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-07-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 119.1 KB
2025-07-24 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.8 KB
2025-07-24 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-07-18 00:00
Report Publication Announcement
결산실적공시예고
Korean 3.8 KB
2025-07-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-06-23 00:00
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
Korean 11.9 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-05-08 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 26.3 KB
2025-05-08 00:00
Remuneration Information
[기재정정]주식매수선택권부여에관한신고
Korean 32.2 KB
2025-05-08 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 28.3 KB

Automate Your Workflow. Get a real-time feed of all ST PHARM CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ST PHARM CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ST PHARM CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NEOGEN CORP Logo
Provides diagnostic tests and genomics services for food, animal, and agricultural safety.
United States of America
NEOG
NEOGENOMICS INC Logo
Provides precision oncology testing for cancer diagnostics, therapy guidance, and research.
United States of America
NEO
NeoImmuneTech, Inc. Logo
Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.
United States of America
950220
NEONC TECHNOLOGIES HOLDINGS, INC. Logo
Developing intranasal drug delivery to treat brain cancer & CNS diseases by crossing the BBB.
United States of America
NTHI
Neumora Therapeutics, Inc. Logo
Developing data-driven precision medicines for neuropsychiatric and neurodegenerative disorders.
United States of America
NMRA
Neuphoria Therapeutics Inc. Logo
Develops novel ion channel modulators for treating neuropsychiatric disorders like anxiety & PTSD.
United States of America
NEUP
NEUROCRINE BIOSCIENCES INC Logo
Develops therapies for neurological, neuroendocrine, and neuropsychiatric disorders.
United States of America
NBIX
Neurogene Inc. Logo
Developing genetic medicines using gene therapy for rare and devastating neurological diseases.
United States of America
NGNE
NeuroSense Therapeutics Ltd. Logo
Developing combination therapies for neurodegenerative diseases, with a focus on ALS.
United States of America
NRSN
NewAmsterdam Pharma Co N.V. Logo
Developing oral LDL-lowering therapies for high-risk cardiovascular disease patients.
United States of America
NAMS

Talk to a Data Expert

Have a question? We'll get back to you promptly.